These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19215194)

  • 1. Risk factors related to a hospital-associated cluster of Clostridium difficile PCR ribotype 027 infections in Germany During 2007.
    Weiss B; Kleinkauf N; Eckmanns T; an der Heiden M; Neumann M; Michels H; Jansen A
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):282-4. PubMed ID: 19215194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.
    Goorhuis A; Debast SB; Dutilh JC; van Kinschot CM; Harmanus C; Cannegieter SC; Hagen EC; Kuijper EJ
    Clin Infect Dis; 2011 Nov; 53(9):860-9. PubMed ID: 21914851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
    Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.
    Muto CA; Pokrywka M; Shutt K; Mendelsohn AB; Nouri K; Posey K; Roberts T; Croyle K; Krystofiak S; Patel-Brown S; Pasculle AW; Paterson DL; Saul M; Harrison LH
    Infect Control Hosp Epidemiol; 2005 Mar; 26(3):273-80. PubMed ID: 15796280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is high consumption of antibiotics associated with Clostridium difficile polymerase chain reaction-ribotype 027 infections in France?
    Birgand G; Miliani K; Carbonne A; Astagneau P
    Infect Control Hosp Epidemiol; 2010 Mar; 31(3):302-5. PubMed ID: 20100084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emergence of Clostridium difficile PCR ribotype 027 in Denmark--a possible link with the increased consumption of fluoroquinolones and cephalosporins?
    Søes L; Mølbak K; Strøbaek S; Truberg Jensen K; Torpdahl M; Persson S; Kemp M; Olsen KE
    Euro Surveill; 2009 Apr; 14(15):. PubMed ID: 19371514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.
    Jamal W; Rotimi VO; Brazier J; Duerden BI
    Anaerobe; 2010 Dec; 16(6):560-5. PubMed ID: 20887795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of imported Clostridium difficile PCR-ribotype 027 infection within the Czech Republic which has a high prevalence of C. difficile ribotype 176.
    Krutova M; Nyc O; Kuijper EJ; Geigerova L; Matejkova J; Bergerova T; Arvand M
    Anaerobe; 2014 Dec; 30():153-5. PubMed ID: 25300750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
    Novell MJ; Morreale CA
    Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of risk factors of Clostridiumdifficile infection in patients hospitalized in the teaching hospital in 2008.
    Dulny G; Zalewska M; Mlynarczyk G
    Przegl Epidemiol; 2013; 67(3):445-50, 547-51. PubMed ID: 24340558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
    Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
    J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
    Kim J; Kang JO; Pai H; Choi TY
    Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.